SLC1A2 and Parkinson disease: We rationalize that a surge in striatal dopamine levels during early PD, as seen in the Thy1-α-synuclein mouse model of PD (Lam et al., 2011) can cause a downregulation of EAAT2 in striatal astrocytes.